Development of an automated noninvasive system for sleep restriction in rodents
Award amount
$852,597Program and phase
STTR · Phase IIAward year
2013Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AFASCI, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- UGMEBNM4WSL6
- Solicitation number
- PA12-089
- Topic code
- NHLBI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
- Accelerating the non-opioid analgesic AFA-281 clinical development with TABA-supported business development
- Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
- Development of a Next Generation Visual Performance Assessment System for Rodents
- IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
- Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
- Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
- The Next Wave of Asthma Therapeutics
- Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications
Research funding history
27 SBIR/STTR records share this UEI (2003–2023). Reported award amounts total $22,071,530. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services